J
James C. Moon
Researcher at University College London
Publications - 649
Citations - 37125
James C. Moon is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Hypertrophic cardiomyopathy. The author has an hindex of 73, co-authored 575 publications receiving 28020 citations. Previous affiliations of James C. Moon include University College Hospital & Barts Health NHS Trust.
Papers
More filters
Journal ArticleDOI
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.
Frank Grothues,Frank Grothues,Gillian C. Smith,James C. Moon,Nicholas G. Bellenger,Peter Collins,Helmut U. Klein,Dudley J. Pennell +7 more
TL;DR: Fast breath-hold cardiovascular magnetic resonance has excellent interstudy reproducibility in normal, dilated, and hypertrophic hearts, and is superior to 2-dimensional echocardiography.
Journal ArticleDOI
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Julian D. Gillmore,Mathew S. Maurer,Rodney H. Falk,Giampaolo Merlini,Thibaud Damy,Angela Dispenzieri,Ashutosh D. Wechalekar,John L. Berk,John L. Berk,Candida Cristina Quarta,Martha Grogan,Helen J. Lachmann,Sabahat Bokhari,Adam Castano,Sharmila Dorbala,Geoff B. Johnson,Andor W. J. M. Glaudemans,Tamer Rezk,Marianna Fontana,Giovanni Palladini,Paolo Milani,P.L Guidalotti,Katarina Flatman,Thirusha Lane,Frederick W. Vonberg,Carol J. Whelan,James C. Moon,Frederick L. Ruberg,Frederick L. Ruberg,Edward J. Miller,David F. Hutt,Bouke P. C. Hazenberg,Claudio Rapezzi,Philip N. Hawkins +33 more
TL;DR: Bone scintigraphy enables the diagnosis of cardiac ATTR amyloidosis to be made reliably without the need for histology in patients who do not have a monoclonal gammopathy, and proposes noninvasive diagnostic criteria that are applicable to the majority of patients with this disease.
Journal ArticleDOI
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance
Jane McCrohon,James C. Moon,Sanjay K Prasad,William J. McKenna,Christine H. Lorenz,Andrew J.S. Coats,Dudley J. Pennell +6 more
TL;DR: Gadolinium CMR is a powerful technique to distinguish DCM from LV dysfunction related to CAD and yields new insights in DCM, and may become a useful alternative to routine coronary angiography in the diagnostic workup of DCM.
Journal ArticleDOI
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
Daniel Messroghli,James C. Moon,Vanessa M Ferreira,Lars Grosse-Wortmann,Taigang He,Peter Kellman,Julia Mascherbauer,Reza Nezafat,Michael Salerno,Erik B. Schelbert,Andrew J. Taylor,Richard B. Thompson,Martin Ugander,Ruud B. van Heeswijk,Matthias G. Friedrich +14 more
TL;DR: This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
Journal ArticleDOI
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
James C. Moon,Daniel Messroghli,Peter Kellman,Stefan K. Piechnik,Matthew D. Robson,Martin Ugander,Peter D. Gatehouse,Andrew E. Arai,Matthias G. Friedrich,Stefan Neubauer,Jeanette Schulz-Menger,Jeanette Schulz-Menger,Erik B. Schelbert +12 more
TL;DR: This document provides recommendations for clinical and research T1 and ECV measurement, based on published evidence when available and expert consensus when not, and addresses controversies in the field.